Alison Rodriguez

The age a woman experiences natural menopause is associated with her risk of developing type 2 diabetes.

Social interaction during chemotherapy treatments can positively influence a cancer patient’s health through improving patient outcomes and patient survival rates.

The FDA recently approved Vosevi-a fixed-dose combination tablet containing FDA-approved sofosbuvir and velpatasvir, and a new drug, voxilaprevi-to treat adults with the hepatitis C virus who do not have cirrhosis (liver disease).

The majority of patients with chronic obstructive pulmonary disease (COPD) do not receive positive airway pressure (PAP) therapy despite its effectiveness in reducing hospitalizations, according to research.

Report notes that 74% of drugs that are currently in development are potentially first-in-class medicines, and 822 drugs in development are for rare diseases.

Patients with long-term conditions are more inclined to choose services with person-centered care attributes, according to recent research.

The FDA is considering adding the risk of ocular inflammatory conditions to labels for 3 immune checkpoint inhibitors due to sight-threatening complications.

Psoriasis, an inflammatory skin disease, is often linked to many comorbidities that affect treatment decisions and the overall management of the disorder, according to new research.

There is an association between the presence of cardiovascular risk factors in adolescence and a lower cognition later in life, regardless of the exposure experienced during adulthood.

The progressive neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and Parkinson disease share the risk factors of increased age and male sex, but new research indicates there is also an association between a patient’s occupation and the mortality rate from these diseases.

A new blood biomarker demonstrates its ability to detect pancreatic cancer earlier, which can lead to better treatment and outcomes, according to a study published in Science Translational Medicine.

According to researchers, additional preventative efforts are necessary to curtail the increasing rate of non-healthcare facility medication errors that can result in serious patient outcomes.

New research suggests that a high fat diet could reduce the bacteria of the gut and, therefore, fight against the harmful inflammation that Crohn’s disease patients experience.

A new study examines the impact that a pharmaceutical’s designation as an orphan drug can have on its manufacturer’s stock prices, and finds that the largest returns were for oncology drugs.

The new long-acting muscarinic antagonist and long-acting beta-agonist (LAMA/LABA) fixed dose combination (FDC) inhaler may be a better option than inhaled corticosteroids (ICS) for long-term use.

A new vaccine may be able to reduce low-density lipoprotein (LDL) cholesterol and, therefore, protect people against the risk of cardiovascular disease.

There is an association between being overweight, abdominal obesity, and a high body fat percentage with a greater risk of rheumatoid arthritis (RA) for women but not men, according to a study.

Severe hemophilia often results in a significant economic and psychological burden on patients, caregivers, and the healthcare system as a whole, according to recent research from Europe.

Novartis’ chimeric antigen receptor T-cell (CAR-T) therapy for treating pediatric leukemia is on the cusp of being the first FDA-approved gene therapy, which will lead to new developments and utilizations of CAR-T therapy for treating other advanced blood cancers.

A new report by the National Academy of Medicine explores how the healthcare system can improve care and manage costs for the 5% of high-need patients who account for almost half of the healthcare spending in the United States.

The incidence of multiply recurrent Clostridium difficile infection is increasing in the United States, leading to a higher demand for new treatments, according to a recent study.

Research published by Cancer Management & Research explores the efficacy of treating multiple malignancies with immune checkpoint inhibitors and programmed cell death-1 inhibitors (PD-1). The review specifically analyzes the presence of pneumonitis as an adverse event following treatment of checkpoint inhibitors.

Narrow insurance coverage has forced some patients to choose between lower premium plans and access to better quality cancer care, according to a recent report.

A study published by BloodAdvances, a Journal of the American Society of Hematology, demonstrated the potential of the 2-pronged approach in treating non-Hodgkin lymphoma, multiple myeloma, and acute myeloid leukemia.

New results from a meta-analysis reveal a decrease in the excess risk of cardiovascular events in patients with rheumatoid arthritis (RA) since the start of the 21st century.

Patients with chronic obstructive pulmonary disease (COPD) often experience chronic pain symptoms, including low physical activity, depression, and hyperinflation, that impact their everyday lives.

Treating myelodysplastic syndrome patients with luspatercept can increase hemoglobin and decrease the burden of red blood cell transfusion for more than 26 months, according to new results from a phase 2 trial.

The BreathLink device is intended to immediately identify any indications of breast cancer based on a 2-minute sample of a patient’s breath.

Stanford Medicine recently published its first annual Health Trends Report, revealing the prominence of big data and the potential difficulties it can produce when attempting to improve the healthcare system.